Positive Bioscience
Positive Bioscience is dedicated to advancing cancer treatment and research, with a focus on immunotherapy and personalized medicine. They provide information on various cancer types, treatment guidelines, and innovative diagnostic approaches, aiming to improve patient outcomes through cutting-edge science and clinical practices.
Industries
Nr. of Employees
medium (51-250)
Positive Bioscience
Mumbai, Maharashtra, India, Asia
Services
Publication of educational reviews and clinical guidance articles on oncology topics including immunotherapy, biomarker methods, and COVID-19–era clinical management.
Development and publication of cancer-care triage guidance and cancer-type specific recommendations intended to support clinicians during constrained-care periods.
Publishing methodological reviews on biomarker estimation (e.g., TMB), describing sequencing approaches, panel calibration, and implications for clinical practice.
Publication of educational reviews and clinical guidance articles on oncology topics including immunotherapy, biomarker methods, and COVID-19–era clinical management.
Development and publication of cancer-care triage guidance and cancer-type specific recommendations intended to support clinicians during constrained-care periods.
Publishing methodological reviews on biomarker estimation (e.g., TMB), describing sequencing approaches, panel calibration, and implications for clinical practice.
Expertise Areas
- Molecular diagnostics and biomarker development
- Genomic sequencing and NGS analysis
- Cancer immunotherapy research and clinical interpretation
- Clinical oncology care pathways and triage under constrained conditions
Key Technologies
- Whole-exome sequencing (WES)
- Targeted NGS gene panels
- Liquid biopsy (circulating tumor DNA, ctDNA)
- Tumor mutational burden (TMB) estimation